All I know is that the company's stable of patents is extensive...

All I know is that the company's stable of patents is extensive and highly relevant.
I looked up midkine on Wikipedia for some independent verification and if what they say is true, the Company is truly undervalued.
midkine offers very,very early detection of illnesses including cancer and inflamatory illnesses such as arthritis.
The benefit of course from early detection is early treatment and therefore higher likelihood of success.

David King is the Chairman and has a very good track record. The MD and CEO, Maria Halalsz, is also very impressive.

It is starting from a low base, has some great potential, it has the right risk/reward characteristics for me....high risk with potentially very high reward. 8D

Good night and good luck!